This is a preview of subscription content, log in via an institution to check access.
Reference
Dakin HA, et al. Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 x 2 x 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning. Value in Health : 18 Aug 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.05.018
Rights and permissions
About this article
Cite this article
Atorvastatin cost effective in T2DM. PharmacoEcon Outcomes News 861, 6 (2020). https://doi.org/10.1007/s40274-020-7088-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7088-7